Allotted Share Options

In accordance with the Power of Attorney given at the general meeting on April 30, 2009, the Board of PCI Biotech ASA has allocated 234,000 share options to key personnel in the company.

Oslo, Norway, June 22, 2009.

The share options have a term of 1.25 to 3 years. Strike price for the share options is NOK 6.80 per share, equal to the average price of the 5 latest days with trading prior to the General Meeting.

The following share options were allocated to the primary insiders (new holding of shares and share options are given in brackets);

  • CEO Per Walday has been allocated 60,000 share options (10,000 shares, 180,000 share options).

  • CFO Bernt-Olav Røttingsnes has been allocated 60,000 share options (0 shares, 60,000 share options).

A total of 114,000 options have been allocated to other key employees.

For further information, please contact:
Per WaldayCEO
Email: pw@pcibiotech.no
Mobil: +47 917 93 429

Newsadmin